T

The National Institute on Drug Abuse (NIDA)

402 employees

National Institute on Drug Abuse (NIDA) is a United States federal-government research institute.

Investor insights

Sectors invested in

Health Care24

Biotechnology19

Pharmaceutical14

Medical10

Biopharma6

Medical Device6

Software6

Therapeutics4

Information Technology4

Neuroscience3

Wellness3

Life Science3

Drug Delivery3

Machine Learning3

neurofeedback3

substance abuse3

wellness3

health care3

mental health care3

behavioral health care3

Funding rounds participated in

$3.4M sweet spot round size

Most of their 37 investments are in rounds between $1.5M and $10M

Investor type

Government Office

Basic info

Industry

research services

Sectors

Addiction Research

Research Training

Research Funding

Date founded

1974

Investments made

T

Tris Pharma raised $17M on August 28, 2023

Investors: The National Institute on Drug Abuse (NIDA)

N

Neurotype Inc. raised $327K on July 1, 2023

Investors: The National Institute on Drug Abuse (NIDA)

U

Undisclosed raised $15M on May 18, 2023

Investors: The National Institute on Drug Abuse (NIDA)

O

OpiAID raised $2.8M on May 3, 2023

Investors: The National Institute on Drug Abuse (NIDA)

O

Omeros Corporation raised $6.7M on April 10, 2023

Investors: The National Institute on Drug Abuse (NIDA)

N

NemaLife, Inc. raised $320K on September 27, 2022

Investors: The National Institute on Drug Abuse (NIDA)

B

Berkshire Biomedical, LLC raised undisclosed on July 25, 2022

Investors: The National Institute on Drug Abuse (NIDA)

E

Enalare Therapeutics Inc. raised undisclosed on July 1, 2022

Investors: The National Institute on Drug Abuse (NIDA)

E

Evon Medics, LLC raised $2.8M on May 9, 2022

Investors: The National Institute on Drug Abuse (NIDA)

B

BioCorRx Pharmaceuticals Inc. raised $3.5M on September 1, 2021

Investors: The National Institute on Drug Abuse (NIDA)

FAQ